| NCT ID | NCT06947200 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Beylikduzu State Hospital |
| Condition | Fibromyalgia |
| Study Type | OBSERVATIONAL |
| Enrollment | 84 participants |
| Start Date | 2025-04-20 |
| Primary Completion | 2025-05-20 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 84 participants in total. It began in 2025-04-20 with a primary completion date of 2025-05-20.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This clinical cross-sectional study will include 84 female patients aged between 18 and 65 years who have been diagnosed with fibromyalgia syndrome according to the 2010 American College of Rheumatology diagnostic criteria. Sociodemographic data will be recorded at the beginning of the study. Pain severity will be assessed using the Visual Analog Scale (VAS). Orthorexia nervosa-related symptoms will be evaluated with the ORTO-11 scale. Body image will be assessed with the Body Appreciation Scale 2, mood will be evaluated using the Hospital Anxiety and Depression Scale (HADS), and fibromyalgia-related impact will be assessed with the Fibromyalgia Impact Questionnaire (FIQ).
Eligibility Criteria
Inclusion Criteria: * Female patients aged 18-65 years. * Diagnosis of fibromyalgia syndrome according to the 2010 American College of Rheumatology diagnostic criteria. * Willingness to participate and provision of written informed consent. Exclusion Criteria: * Refusal to participate. * Presence of diagnosed psychiatric disorders. * Presence of cognitive impairment. * Use of medications that may affect mood.
Frequently Asked Questions
Who can join the NCT06947200 clinical trial?
This trial is open to female participants only, aged 18 Years or older, up to 65 Years, studying Fibromyalgia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06947200 currently recruiting?
Yes, NCT06947200 is actively recruiting participants. Visit ClinicalTrials.gov or contact Beylikduzu State Hospital to inquire about joining.
Where is the NCT06947200 trial being conducted?
This trial is being conducted at Istanbul, Turkey (Türkiye).
Who is sponsoring the NCT06947200 clinical trial?
NCT06947200 is sponsored by Beylikduzu State Hospital. The trial plans to enroll 84 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.